Trimeris' Unattributed VC - IV Round

Trimeris raised a round of funding on April 01, 1997.

Trimeris is a development stage, biopharmaceutical company engaged in the discovery and development of novel therapeutic agents that block viral infection by inhibiting viral fusion with host cells. T…

Articles about Trimeris' Unattributed VC - IV Round: